Prevention of lethal hepatic injury in Long-Evans Cinnamon (LEC) rats by D-galactosamine hydrochloride

DOI 機関リポジトリ Web Site 被引用文献1件 参考文献30件
  • Otsuka Toshihiro
    Department of Digestive and Pediatric Surgery, The University of Tokushima Graduate School
  • Izumi Keisuke
    Department of Molecular and Environmental Pathology, The University of Tokushima Graduate School
  • Tokunaga Itsuo
    Department of Legal Medicine, The University of Tokushima Graduate School
  • Gotohda Takako
    Department of Legal Medicine, The University of Tokushima Graduate School
  • Ipposhi Kaneshige
    Department of Clinical Pharmacology, Institute of Health Biosciences, The University of Tokushima Graduate School
  • Takiguchi Yoshiharu
    Department of Clinical Pharmacology, Institute of Health Biosciences, The University of Tokushima Graduate School
  • Kaneda Shinya
    Department of Molecular and Environmental Pathology, The University of Tokushima Graduate School
  • Satake Nobuo
    Department of Molecular and Environmental Pathology, The University of Tokushima Graduate School
  • Ohnishi Takamasa
    Department of Molecular and Environmental Pathology, The University of Tokushima Graduate School
  • Tashiro Seiki
    Department of Digestive and Pediatric Surgery, The University of Tokushima Graduate School
  • Shimada Mitsuo
    Department of Digestive and Pediatric Surgery, The University of Tokushima Graduate School

この論文をさがす

抄録

Repeated injections of D-galactosamine hydrochloride (GalN) increase the survival rate of Long-Evans Cinnamon (LEC) rats, an animal model of Wilson’s disease. The aim of the present study was to investigate the mechanism of GalN for prevention of spontaneous lethal hepatic injury in LEC rats. Male LEC rats were given a single subcutaneous injection of 300 mg/kg of GalN or vehicle (0.9% NaCl) at 14 weeks, and killed at 28 weeks of age. Next, 6-week-old male LEC rats were given weekly subcutaneous injections of 300 mg/kg of GalN or vehicle for 3 or 12 weeks, and their hepatic 8-hydroxydeoxy-2’-guanosine (8-OHdG), glutathione peroxidase (GPX), and catalase activities were measured. None of GalN-treated rats died of hepatic injury (0/12), whereas the mortality rate of control rats given 0.9% NaCl was 17% (2/12). GalN administration for 12 weeks decreased the hepatic 8-OHdG, and GalN administration for either 3 or 12 weeks increased the glutathione peroxidase activity. GalN administration increased the serum level of alanine aminotransferase, and accelerated megalocytic degeneration of the hepatocytes. GalN treatment is effective in preventing lethal hepatitis in LEC rats and decrease of oxidative DNA damage by GalN plays an important role in increase of the survival rate. 53: 81-86, February, 2006

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (30)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ